免疫疗法
无容量
背向效应
肿瘤科
易普利姆玛
彭布罗利珠单抗
内科学
阿替唑单抗
肝癌
PD-L1
作者
Byung Min Lee,Jinsil Seong
标识
DOI:10.3748/wjg.v27.i10.919
摘要
In the immune oncology era, the clinical efficacy of immune checkpoint inhibitors (ICIs) against most solid cancers is well known. In hepatocellular carcinoma, the recent success of combination therapy with targeting agents has accelerated the search for novel combination strategies. Radiotherapy (RT), an attractive modality, can be combined with ICIs, which act as strong modulators of the tumor immune microenvironment. Herein, we discuss immune modulation caused by radiation and the current trials of RT-ICI combination treatment as well as future perspectives.
科研通智能强力驱动
Strongly Powered by AbleSci AI